A vision for the future of radiotherapy

Elekta has announced its plans for the commercial release of Atlantic - a high-field MRI-guided radiation therapy system. The anticipated game-changing technology will be introduced in 2017, with the first systems delivered a year later. In 2012, as part of a wider engagement, DCA Design International worked with Elekta to create a future vision for the industrial design and usability of the Atlantic system.

The extensive project drew on DCA’s full-service offering. The future vision was informed by a detailed evidence base and grounded with collaborative technical review. A body of evidence was collected from visits to seven treatment sites worldwide, over 90 hours of observations (approximately 360 treatment sessions) and over 50 in-depth interviews with healthcare professionals, thought leaders and system stakeholders.

As well as providing a grounded, aspirational vision for the Atlantic system, the broad evidence base and detailed design language have informed the development of a number of other projects within Elekta.

‘It was a real pleasure for DCA to work with Elekta’s Atlantic project team on such an exciting and game-changing development. Throughout the engagement Elekta clearly demonstrated a commitment to evidence-based decision-making, placing the needs of the patients and healthcare professionals firmly at the centre of their vision for the future of radiotherapy, affirming their position as a world leader in their field’. Rob Woolston (DCA’s -Managing Director).

• Link to Medical and Scientific